We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Nitinol Stone Extractor Demonstrates Enhanced Retention Strength

By HospiMedica staff writers
Posted on 03 Jun 2008
A new stone extraction device allows physicians to easily engage, release, and extract kidney and urinary tract stones while providing improved irrigation, visibility, and enhanced efficiency. More...


The NGage stone extractor is based on nickel-titanium (nitinol) technology; as a result, the extractor retains its shape following extreme torsion, yet is flexible enough for a physician to guide during stone manipulation without damage to surrounding renal tissue. The duality of the NGage is designed to secure and grip kidney or ureteral stones firmly and also extract and release the stones easily, enabling urologists greater control during stone retrieval procedures. Available in a variety of sizes, and diameters of 1.7 French and 2.2 French, the NGage approaches various procedural needs with increased flow, enhanced visibility, and improved deflection, allowing physicians to entrap stone fragments as small as one mm. In a calyceal model, the NGage demonstrated a superior ability to release stone fragments when compared with both standard and multi wire nitinol baskets. The NGage Nitinol Stone Extractor is manufactured by Cook Medical (Bloomington, IN, USA).

"The NGage has demonstrated a superior ability to securely capture and release kidney stones throughout the urinary tract, even in the most challenging locations,” said Jerry French, senior vice president and global strategic business unit leader for Cook Medical's urology division. "We are pleased to now offer this device to physicians, as part of Cook's ongoing efforts to help urologists render their patients stone-free.”

"Our studies at UTSW [University of Texas Southwestern Medical Center; Dallas, TX, USA] show that NGage has 50% greater retention strength than traditional graspers,” explained Dr. Margaret Pearle, M.D., a professor of urology and internal medicine at the UTSW. "The device also has demonstrated a superior ability to release simulated stone fragments when compared to both standard and multi-wire nitinol stone extraction baskets.”


Related Links:
Cook Medical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.